{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:22:43Z","timestamp":1784211763467,"version":"3.55.0"},"reference-count":29,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1254\/jphs.13020fp","type":"journal-article","created":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T23:16:04Z","timestamp":1372288564000},"page":"205-212","source":"Crossref","is-referenced-by-count":11,"title":["Effects of the Fluoroquinolone Antibacterial Drug Ciprofloxacin on Ventricular Repolarization in the Halothane-Anesthetized Guinea Pig"],"prefix":"10.1254","volume":"122","author":[{"given":"Kazuhiro","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Omuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Belardinelli L, Antzelevitch C, Vos MA. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci. 2003;24:619\u2013625.","DOI":"10.1016\/j.tips.2003.10.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Redfern WS, Carlsson L, Davis AS, Lynch WG, Mackenzie I, Palethorpe S, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58:32\u201345.","DOI":"10.1016\/S0008-6363(02)00846-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B. Torsades de pointe probably related to sparfloxacin. Eur J Clin Microbiol Infect Dis. 1996;15:350\u2013351.","DOI":"10.1007\/BF01695673"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Demolis JL, Charransol A, Funck-Brentano C, Jaillon P. Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers. Br J Clin Pharmacol. 1996;41:499\u2013503.","DOI":"10.1046\/j.1365-2125.1996.03394.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Satoh Y, Sugiyama A, Chiba K, Tamura K, Hashimoto K. QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring. J Cardiovasc Pharmacol. 2000;36:510\u2013515.","DOI":"10.1097\/00005344-200010000-00015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bischoff U, Schmidt C, Netzer R, Pongs O. Effects of fluoroquinolones on HERG currents. Eur J Pharmacol. 2000;406:341\u2013343.","DOI":"10.1016\/S0014-2999(00)00693-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lacroix P, Crumb WJ, Durando L, Ciottoli GB. Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk. Eur J Pharmacol. 2003;477:69\u201372.","DOI":"10.1016\/S0014-2999(03)02180-0"},{"key":"8","unstructured":"8 Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M. Levofloxacin-Surveillance Group. In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010. Jpn J Antibiot. 2012;65:181\u2013206."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Prabhakar M, Krahn AD. Ciprofloxacin-induced acquired long QT syndrome. Heart Rhythm. 2004;1:624\u2013626.","DOI":"10.1016\/j.hrthm.2004.06.020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Letsas KP, Sideris A, Kounas SP, Efremidis M, Korantzopoulos P, Kardaras F. Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine. Int J Cardiol. 2006;109:273\u2013274.","DOI":"10.1016\/j.ijcard.2005.04.031"},{"key":"11","unstructured":"11 Keivanidou A, Arnaoutoglou C, Krommydas A, Papanikolaou G, Tsiptses K, Chrisopoulos C, et al. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. Cardiol J. 2009;16:172\u2013174."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother. 1993;37:1073\u20131081.","DOI":"10.1128\/AAC.37.5.1073"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ambrose PG, Grasela DM, Grasela TH, Passarell J, Mayer HB, Pierce PF. Pharmacodynamics of fluoroquinolones against <i>Streptococcus pneumoniae<\/i> in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother. 2001;45:2793\u20132797.","DOI":"10.1128\/AAC.45.10.2793-2797.2001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ghaffari MS, Parsamehr R. The effects of intravenous ciprofloxacin on the electrocardiogram of healthy dogs. Vet Res Commun. 2009;33:987\u2013990.","DOI":"10.1007\/s11259-009-9317-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Takahara A, Sugiyama A, Hashimoto K. Reduction of repolarization reserve by halothane anesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. Br J Pharmacol. 2005;146:561\u2013567.","DOI":"10.1038\/sj.bjp.0706352"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Takahara A, Sasaki R, Nakamura M, Sendo A, Sakurai Y, Namekata I, et al. Clobutinol delays ventricular repolarization in the guinea pig heart: comparison with cardiac effects of HERG K+ channel inhibitor E-4031. J Cardiovasc Pharmacol. 2009;54:552\u2013559.","DOI":"10.1097\/FJC.0b013e3181bfb17c"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Takahara A, Fujiwara K, Ohtsuki A, Oka T, Namekata I, Tanaka H. Effects of the antitussive drug cloperastine on ventricular repolarization in halothane-anesthetized guinea pigs. J Pharmacol Sci. 2012;120:165\u2013175.","DOI":"10.1254\/jphs.12117FP"},{"key":"18","unstructured":"18 The ICH Steering Committee. The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs (E14). The international conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH). The Guideline was recommended for adoption at Step 4 of the ICH process in May 2005 (http:\/\/www.ich.org\/)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Van de Water A, Verheyen J, Xhonneux R, Reneman RS. An improved method to correct the QT interval of the electrocardiogram for change in heart rate. J Pharmacol Methods. 1998;22:207\u2013217.","DOI":"10.1016\/0160-5402(89)90015-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Sakaguchi Y, Takahara A, Nakamura Y, Akie Y, Sugiyama A. Halothane-anesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation. Basic Clin Pharmacol Toxicol. 2009;104:43\u201348.","DOI":"10.1111\/j.1742-7843.2008.00312.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Takahara A, Nakamura Y, Sugiyama A. Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone. Eur J Pharmacol. 2008;596:127\u2013131.","DOI":"10.1016\/j.ejphar.2008.08.018"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs. 1999;58 Suppl 2:29\u201336.","DOI":"10.2165\/00003495-199958002-00006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Takahara A, Sugiyama A, Satoh Y, Wang K, Honsho S, Hashimoto K. Halothane sensitizes the canine heart to pharmacological I<sub>Kr<\/sub> blockade. Eur J Pharmacol. 2005;507:169\u2013177.","DOI":"10.1016\/j.ejphar.2004.11.045"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Dixon R, Job S, Oliver R, Tompson D, Wright JG, Maltby K, et al. Lamotrigine does not prolong QTc in a thorough QT\/QTc study in healthy subjects. Br J Clin Pharmacol. 2008;66:396\u2013404.","DOI":"10.1111\/j.1365-2125.2008.03250.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Matthys G, Park JW, McGuire S, Wire MB, Zhang J, Bowen C, et al. Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects. Br J Clin Pharmacol. 2010;70:24\u201333.","DOI":"10.1111\/j.1365-2125.2010.03646.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Demolis JL, Charransol A, Funck-Brentano C, Jaillon P. Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers. Br J Clin Pharmacol. 1996;41:499\u2013503.","DOI":"10.1046\/j.1365-2125.1996.03394.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Thomsen MB, Verduyn SC, Stengl M, Beekman JD, de Pater G, van Opstal J, et al. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation. 2004;110:2453\u20132459.","DOI":"10.1161\/01.CIR.0000145162.64183.C8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Takahara A, Sugiyama A, Ishida Y, Satoh Y, Wang K, Nakamura Y, et al. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H<sub>1<\/sub> blocker terfenadine-induced torsades de pointes arrhythmias. Br J Pharmacol. 2006;147:634\u2013641.","DOI":"10.1038\/sj.bjp.0706493"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Ranger S, Nattel S. Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs. Circulation. 1995;92:1300\u20131311.","DOI":"10.1161\/01.CIR.92.5.1300"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/122\/3\/122_13020FP\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:10:23Z","timestamp":1621437023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/122\/3\/122_13020FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.13020fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}